+ Follow ELI LILLY PHILS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1255962
[Title] => FDA recalls unregistered erectile dysfunction drug
[Summary] => The Food and Drug Administration (FDA) has ordered the recall of Cialis (generic name tadalafil) 20-milligram tablet, a drug for erectile dysfunction that was found to be unregistered.
[DatePublished] => 2013-11-13 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Metro
[SectionUrl] => metro
[URL] =>
)
[1] => Array
(
[ArticleID] => 235415
[Title] => Eli Lilly Philippines bares restructured operations
[Summary] => Eli Lilly Phils. has announced a reorganization of its operations in the Philippines.
The restructuring includes a reorganization of resources and a reduction in the work force to reflect significant changes in the Philippine market and in its product mix. Henceforth, Pharmalink, a division of Zuellig Pharma Inc. will market the retail products Axid, Ceclor, Dobutrex, Ilosene, Keflex, Tapazole and Vancocin.
[DatePublished] => 2004-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
ELI LILLY PHILS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1255962
[Title] => FDA recalls unregistered erectile dysfunction drug
[Summary] => The Food and Drug Administration (FDA) has ordered the recall of Cialis (generic name tadalafil) 20-milligram tablet, a drug for erectile dysfunction that was found to be unregistered.
[DatePublished] => 2013-11-13 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Metro
[SectionUrl] => metro
[URL] =>
)
[1] => Array
(
[ArticleID] => 235415
[Title] => Eli Lilly Philippines bares restructured operations
[Summary] => Eli Lilly Phils. has announced a reorganization of its operations in the Philippines.
The restructuring includes a reorganization of resources and a reduction in the work force to reflect significant changes in the Philippine market and in its product mix. Henceforth, Pharmalink, a division of Zuellig Pharma Inc. will market the retail products Axid, Ceclor, Dobutrex, Ilosene, Keflex, Tapazole and Vancocin.
[DatePublished] => 2004-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest
January 17, 2004 - 12:00am